News|Articles|October 2, 2025

Q3 2025 Recap: Allergy News and Updates

Explore the latest advancements in allergy and immunology, including new therapies, FDA approvals, and innovative clinical strategies for improved patient care from Q3.

As Q3 closes, HCPLive revisits key advances in allergy and immunology, highlighting emerging therapies and practical clinical strategies. Over the past months, clinicians have gained insight into intranasal epinephrine for anaphylaxis, the expanding role of brief cognitive behavioral therapy (bCBT) for food allergy–related anxiety, and the integration of motivational interviewing to improve patient adherence and outcomes.